Why have shares in FTSE 100 pharma group Shire been falling since 2016?
FTSE 100 biopharmaceutical company Shire (SHP) has been fighting negative investor sentiment for more than a year amid concerns over debt pressures and competitive threats.The decision to potentially spin off part of its business...
01 February 2018